STEMLENTA

LIVE

Serial Number

79219026

Owner

bluebird bio, Inc.

Filing Date

Aug 15, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

STEMLENTA Trademark

Serial Number: 79219026 • Registration: 5557779

STEMLENTA is a trademark filed by bluebird bio, Inc. on August 15, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

bluebird bio, Inc. (77 trademarks)

455 Grand Union Blvd

Entity Type: 03

Bluebird Bio (UK) Ltd. (46 trademarks)

Belvedere House,

Entity Type: 99

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

Legal Representation

Correspondence Address

John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C.

530 Virginia Road, P.O. Box 9133

Concord, MA 01742-9133

UNITED STATES

Trademark Details

Filing Date

August 15, 2017

Registration Date

September 11, 2018

Published for Opposition

June 26, 2018

Cancellation Date

March 28, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of genetic diseases

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 18, 2025 ADCH

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Nov 28, 2025 INTR

NEW REPRESENTATIVE AT IB RECEIVED

Nov 13, 2025 NREP

CANCELLED SECTION 71

Mar 28, 2025 C71T

NEW REPRESENTATIVE AT IB RECEIVED

Sep 13, 2024 NREP

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 23, 2023 ADCH

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Sep 11, 2023 REM3

NEW REPRESENTATIVE AT IB RECEIVED

Nov 15, 2019 NREP

NEW REPRESENTATIVE AT IB RECEIVED

Oct 18, 2019 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

Jan 11, 2019 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Dec 20, 2018 FICS

FINAL DISPOSITION PROCESSED

Dec 20, 2018 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Dec 11, 2018 FICR

CHANGE OF OWNER RECEIVED FROM IB

Nov 8, 2018 CHLD

REGISTERED-PRINCIPAL REGISTER

Sep 11, 2018 R.PR

ATTORNEY REVIEW COMPLETED

Aug 7, 2018 ATRV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

Aug 2, 2018 CREV

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 26, 2018 NPUB

PUBLISHED FOR OPPOSITION

Jun 26, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 6, 2018 NONP

CORRECTION TRANSACTION RECEIVED FROM IB

Jun 1, 2018 CRCV

APPROVED FOR PUB - PRINCIPAL REGISTER

May 17, 2018 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 8, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 8, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 8, 2018 TROA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 23, 2018 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 23, 2018 REAP

REFUSAL PROCESSED BY IB

Feb 3, 2018 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 23, 2017 RFCS

REFUSAL PROCESSED BY MPU

Dec 23, 2017 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 13, 2017 RFCR

NON-FINAL ACTION WRITTEN

Dec 12, 2017 CNRT

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

Dec 1, 2017 RFWR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Nov 19, 2017 RFCR

NON-FINAL ACTION WRITTEN

Nov 18, 2017 CNRT

ASSIGNED TO EXAMINER

Nov 16, 2017 DOCK

APPLICATION FILING RECEIPT MAILED

Oct 31, 2017 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 25, 2017 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 19, 2017 REPR

Related Trademarks

More from this Owner

G GENETIX BIOTHERAPEUTICS

GENETIX BIOTHERAPEUTICS

ZYNTEGLO

More in Same Class

CLARIXX